| Trial ID: | L5990 |
| Source ID: | NCT03030300
|
| Associated Drug: |
Novolin 30r;Pioglitazone;Metformin
|
| Title: |
Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes
|
| Interventions: |
DRUG: Novolin 30R;Pioglitazone;Metformin
|
| Outcome Measures: |
Primary: prolonged-remission rate, hyperglycemia below diagnostic thresholds for diabetes without active pharmacologic therapy or ongoing procedures of 5 years' duration., 5 years|partial-remission rate, hyperglycemia below diagnostic thresholds for diabetes without active pharmacologic therapy or ongoing procedures of more than 3 months' duration, and less than 5 years., 5 years |
|
| Sponsor/Collaborators: |
Sponsor: Qianfoshan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
170
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2015-02
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-25
|
| Locations: |
Shandong Provincial Hospital, Jinan, Shandong, 250001, China|Qianfoshan Hospital, Jinan, Shandong, 250012, China|Qilu Hospital, Jinan, Shandong, 250014, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03030300
|
